Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 8161 AL 8175

Key biomarkers in Alzheimer's disease: Insights for diagnosis and treatment strategies

Jamal R, Shaikh MA, Taleuzzaman M, Haque Z, Albratty M, Alam MS, Makeen HA, Zoghebi K, Saleh SF.

J Alzheimers Dis. 2025 Jun;105(3):679-696. doi: 10.1177/13872877251330500. Epub 2025 Apr 21.

Blood biomarkers of Alzheimer's disease: Balancing clinical relevance with improved accessibility and sustainability

Daly T.

Adv Clin Exp Med. 2025 Nov;34(11):1807-1812. doi: 10.17219/acem/208917.

Advances in Diagnostics and Treatments for Alzheimer's Disease

Sunderland A, Thatcher AL, Rackley EV, Kuruvilla T.

Br J Hosp Med (Lond). 2025 Dec 25;86(12):1-19. doi: 10.12968/hmed.2025.0492. Epub 2025 Dec 19.

Blood pressure and Alzheimer's disease biomarkers in cognitively unimpaired adults: a multicenter study

Osset-Malla M, Martínez-Velasco A, Sánchez-Benavides G, Buongiorno M, de la Sierra A, Shekari M, Minguillon C, Kollmorgen G, Quijano-Rubio C, Zetterberg H, Blennow K, García DV, Suárez-Calvet M, Gispert JD, Grau-Rivera O; ALFA Study.

J Prev Alzheimers Dis. 2025 Dec;12(10):100304. doi: 10.1016/j.tjpad.2025.100304. Epub 2025 Aug 11.

TREM2 and LAG-3 in cancer and Alzheimer's disease immunotherapy

Yuan S, Fuchs NS, Abdel-Rahman SA, Kaur B, Gabr MT.

Trends Pharmacol Sci. 2025 Aug;46(8):738-751. doi: 10.1016/j.tips.2025.06.010. Epub 2025 Jul 18.

Translating Alzheimer's Disease Mechanisms into Therapeutic Opportunities

Li J, Wang L, Zhang X, Shi J, Zhu Y, Wang H, Zhu X, Zhu Q, Luo JL.

Biomolecules. 2025 Sep 8;15(9):1290. doi: 10.3390/biom15091290.

A brief history of Aβ imaging

Cohen AD, Villemagne VL.

Alzheimers Dement. 2025 May;21(5):e70291. doi: 10.1002/alz.70291.

Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial

Faridar A, Gamez N, Li D, Wang Y, Boradia R, Thome AD, Zhao W, Beers DR, Thonhoff JR, Nakawah MO, Román GC, Volpi JJ, Toledo JB, George M, Davis CS, Pascual B, Grundman M, Masdeu JC, Appel SH.

Alzheimers Res Ther. 2025 Jul 4;17(1):146. doi: 10.1186/s13195-025-01791-x.

Towards pharmacological prevention of Alzheimer disease

Llibre-Guerra JJ, McDade EM, Schindler SE, Clifford DB, Supnet C, Atri A, Bateman RJ.

Nat Rev Neurol. 2025 Dec;21(12):721-733. doi: 10.1038/s41582-025-01154-y. Epub 2025 Nov 3.

Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study

Doecke JD, Bellomo G, Vermunt L, Alcolea D, Halbgebauer S, In 't Veld S, Mattsson-Carlgren N, Veverova K, Fowler CJ, Boonkamp L, Houtkamp IM, Koel-Simmerlink M, Verberk IMW, Gaetani L, Toja A, Wojdała AL, Fortea J, Pijnenburg Y, Lemstra A, van der Flier W, Hort J, Otto M, Hansson O, Parnetti L, Masters CL, Lleó A, González-Escalante A, Contador J, Suárez-Calvet M, Fernández-Lebrero A, Puig-Pijoan A, Ortiz-Romero P, Jiménez-Moyano E, Minguillón C, Del Campo M, Teunissen C.

Alzheimers Dement. 2025 Jun;21(6):e14573. doi: 10.1002/alz.14573.

Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study

Zúñiga CH, Acosta BI, Menchaca R, Amescua CA, Hong S, Hui L, Gil M, Rhee YH, Yoon S, Kim M, Chang PY, Kim YM, Song PY, Betito K.

Alzheimers Res Ther. 2025 Feb 12;17(1):40. doi: 10.1186/s13195-025-01681-2.

The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology

McDade EM, Barthélemy NR, Wang G, Li Y, Cao Y, Gordon B, Benzinger TLS, Clifford D, Goate AM, Renton AE, Hassenstab J, Llibre-Guerra JJ, Perrin RJ, Xiong C, Cruchaga C, Mummery CJ, Berman SB, Lah J, Roberson ED, Van Dyck C, Gauthier S, Masters CL, Masellis M, Bittner T, Yaari R, Chhatwal J, Chrem P, Brooks W, Suzuki K, Levin JJ, Jucker M, Ringman J, Wallon D, Ikeuchi T, Lee JH, Roh JH, Schofield P, Fox NC, Ryan NS, Vöglein J, Karch C, Ibáñez L, Day GS, Sánchez-Valle R, Daniels A, Morris JC, Supnet-Bell C, Levey AI, Bateman RJ; DIAN‐TU Study Team and DIAN Obs Team.

Alzheimers Dement. 2025 Sep;21(9):e70689. doi: 10.1002/alz.70689.

Lecanemab treatment for Alzheimer's Disease of varying severities and associated plasma biomarkers monitoring: A multi-center real-world study in China

Chen S, Ou R, Wei Q, Li C, Song W, Zhao B, Yang J, Fu J, Ma Y, Liu J, Wang X, Fang D, Hu T, Xiao L, Zhang S, Huang R, Guo X, Feng F, Chen X, Shang H.

Alzheimers Dement. 2025 Oct;21(10):e70750. doi: 10.1002/alz.70750.

Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer's Disease

Liu X, Baxley S, Hebron M, Turner RS, Moussa C.

Int J Mol Sci. 2025 May 23;26(11):5044. doi: 10.3390/ijms26115044.

Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium

Verberk IMW, Gouda M, Antwi-Berko D, van Leeuwenstijn M, Bongers B, Houtkamp IM, van der Flier WM, Janelidze S, Hansson O, Bastard NL, Vandijck M, Hunter J, Honigberg L, Kirmess KM, Verghese PB, Blennow K, Zetterberg H, Meyers EA, Edelmayer RM, Teunissen C.

Alzheimers Dement. 2025 Oct;21(10):e70752. doi: 10.1002/alz.70752.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias